Obesity Trial, Recruiting (NCT06345586)

Obesity Trial, Recruiting NCT06345586 Sponsor: Chulalongkorn University Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06345586 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Thai women between 18 and 45 years old who are living with obesity and have a scheduled bariatric (weight-loss) surgery appointment at Chulalongkorn Hospital
Women who need a form of birth control
Women who are able to use non-hormonal birth control methods during the study period
Women who are willing and able to give their consent to participate

Who may not be able to join:

Women who are currently pregnant or who have given birth within the last 3 months
Women who have been breastfeeding within the last 6 months
Women who have used a contraceptive injection called DMPA within the last 12 months
Women who have used any other hormonal birth control pills within the last 4 weeks
Women who have had both ovaries removed or have had a hysterectomy (removal of the uterus)
Women with a suspected ovarian tumour or an abnormal ovarian cyst
Women who smoke cigarettes regularly
Women who have a medical reason that means they should not take a hormone called Drospirenone (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Punyawee Utaipatanacheep, Chulalongkorn University

Phone: +668-7515-4003

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06345586

Sponsor: Chulalongkorn University

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: +668-7515-4003

More information: https://clinicaltrials.gov/study/NCT06345586

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Thai women between 18 and 45 years old who are living with obesity and have a scheduled bariatric (weight-loss) surgery appointment at Chulalongkorn Hospital
Women who need a form of birth control
Women who are able to use non-hormonal birth control methods during the study period
Women who are willing and able to give their consent to participate

Who may not be able to join:

Women who are currently pregnant or who have given birth within the last 3 months
Women who have been breastfeeding within the last 6 months
Women who have used a contraceptive injection called DMPA within the last 12 months
Women who have used any other hormonal birth control pills within the last 4 weeks
Women who have had both ovaries removed or have had a hysterectomy (removal of the uterus)
Women with a suspected ovarian tumour or an abnormal ovarian cyst
Women who smoke cigarettes regularly
Women who have a medical reason that means they should not take a hormone called Drospirenone (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chulalongkorn University

Registry

ClinicalTrials.gov

Start date

18 April 2024

Est. completion

1 July 2026

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Cervical mucus by modified Insler score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov